ARTIVA BIOTHERAP (ARTV): Institutional Ownership
Hedge funds and institutional managers reporting a position in ARTV · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
5
13F filers
Aggregate Value
$1.4M
Across holders
Last Price
$9.62
2026-06-26
Sector
Health Care
GICS
Holder activity3 new0 added2 reduced
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP CIK 0001179392 | Hedge Fund | 115K | $741K | 51.7% | 0.0% | Reduced | $-192K | Q1 2026 |
| RENAISSANCE TECHNOLOGIES LLC CIK 0001037389 | Hedge Fund | 80K | $515K | 36.0% | 0.0% | Reduced | $-233K | Q1 2026 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 16K | $102K | 7.1% | 0.0% | New | — | Q1 2026 |
| Qube Research & Technologies Ltd CIK 0001729829 | Hedge Fund | 26K | $73K | 5.1% | 0.0% | New | — | Q3 2025 |
| MARSHALL WACE, LLP CIK 0001318757 | Hedge Fund | 431 | $2K | 0.1% | 0.0% | New | — | Q4 2025 |
Reduced
Hedge Fund
$741K· 51.7% of total· 0.0% port· 115K sh· $-192K QoQ· Q1 2026
Reduced
Hedge Fund
$515K· 36.0% of total· 0.0% port· 80K sh· $-233K QoQ· Q1 2026
New
Hedge Fund
$102K· 7.1% of total· 0.0% port· 16K sh· — QoQ· Q1 2026
New
Hedge Fund
$73K· 5.1% of total· 0.0% port· 26K sh· — QoQ· Q3 2025
New
Hedge Fund
$2K· 0.1% of total· 0.0% port· 431 sh· — QoQ· Q4 2025